healio.com /1 week ago

Liver disease risk scores may predict cirrhosis, but not HCC

Among nine available risk scores for steatotic liver disease, none were able to reliably predict elevated risk for hepatocellular carcinoma and one appeared most beneficial for cir...

Read source
bioengineer.org /3 weeks ago

ORC1 Protein Rises with HBV Liver Disease Progression and Flags Poorer Survival

A study of 178 patients found that ORC1 expression rises from chronic hepatitis B to cirrhosis to HBV-associated liver cancer and that high expression is associated with poorer sur...

Read source
bioengineer.org /5 days ago

Hypoxia-Driven SPP1 Macrophages Promote Fibrosis and Chemoembolization Resistance in Liver Cancer

Spatial multi-omic profiling reveals that transarterial chemoembolization promotes hypoxia-driven SPP1-positive macrophages that produce fibronectin, build immunosuppressive fibrot...

Read source
healio.com /3 weeks ago

Liver Cancer Awareness Month: The importance of universal hepatitis B vaccination

For this Liver Cancer Awareness Month, we must remember to universally administer the hepatitis B virus vaccine to newborns, children and adults to prevent liver cancer.The hepatit...

Read source
bioengineer.org /1 week ago

Cellular Study Links Hepatitis B Mutation to Altered Liver Cell Mechanics

A laboratory study using Huh-7 cell cultures found that hepatitis B virus subgenotype A1 and its G1862T mutation alter cellular mechanics and beta-catenin localisation.

Read source
koreatimes.co.kr /1 month ago

HLB resubmits FDA application for liver cancer treatment

Korean drugmaker HLB has resubmitted its application for U.S. approval of a combination therapy for advanced liver cancer, renewing its push to bring the target treatment to market...

Read source
bioengineer.org /3 weeks ago

Research report: Hypoxia-induced GP73 promotes the Warburg effect in hepatocellular carcinoma via HIF-1α

A cell and patient-cohort study links hypoxia-induced GP73 to HIF-1α-dependent glycolysis, growth, invasion and markers of transarterial chemoembolization resistance in hepatocellu...

Read source
healio.com /3 weeks ago

Caring for patients with immunotherapy-related hepatitis

NASHVILLE — In this video, Elliot Tapper, MD, FAASLD, discusses a presentation from the ACG Annual Meeting about when it is safe to stop cancer therapy when it results in hepatitis...

Read source
healio.com /1 month ago

Liver transplant for colorectal liver metastases ‘promising’

NASHVILLE, Tenn. — Liver transplantation yielded favorable short- and intermediate-term outcomes for patients with unresectable colorectal liver metastases confined to the liver, a...

Read source
healio.com /3 weeks ago

Recent developments may change care landscape in hepatitis B

NASHVILLE — In this Healio video, Arun B. Jesudian, MD, discusses hepatitis B developments including new therapies for highly selective patients, updated treatment guidelines and d...

Read source
goodmenproject.com /3 weeks ago

Liver Cancer Deaths Surge 27% in a Decade – the Fastest Rise of Any Major Cancer

Liver cancer deaths in England and Wales rose nearly 27% over a decade, highlighting urgent needs for prevention and earlier diagnosis. The post Liver Cancer Deaths Surge 27% in a...

Read source
goodmenproject.com /1 month ago

Liver Cancer Can Be Preventable. Do You Know the Treatable Risk Factors?

Several health issues tied to liver disease can be managed or treated before they lead to cirrhosis or cancer. A liver specialist explains the connection The post Liver Cancer Can...

Read source
salud-america.org /1 month ago

What is Driving the High Rates of Liver Cancer Among Latinos?

This blog was published as part of a collaboration between Salud America! and the Prevent Cancer Foundation in honor of Hispanic Heritage Month. Did you know that Latinos have a hi...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.